Cheers to that, Grip. Glad you had an opportunity to make some money. I didn’t learn about CYDY until last June. So, yeah, I got caught in the run up to $10 before I’d really had a chance to do a lot of research, and FOMO caused my initial position to have quite a bit higher basis than your $0.30. But I’ve averaged back down to a very comfortable basis since then. All the while learning more and more about both the drug and the company. And I have to say, I’m personally very comfortable with what I’m holding.
If you have the kind of personality that allows you to ignore the “If I’d just held onto my $0.30 shares from the start....” voice in the back of your head if and when an approval is given to Leronlimab, then I applaud you. I personally can’t drown out that voice. That’s why I prefer to buy and hold stocks rather than trade them.
You’re absolutely right. People have placed their bets. So all we have to do now is wait to see which horse crosses the line first. Everything else - all the talk and prognosticating - is meaningless in the end, because none of it has any effect on what will ultimately happen.
Market Data 
Markets 
AI
